CABAZITAXEL Teva conc perf 60 mg/6ml flac 6 ml
7680685970015
CH-68597
L01CD04
07.16.1.
Reimbursement limitations:
CABAZITTE.02
En association avec la prednisone ou la prednisolone, pour le traitement de patients atteints d'un …
1 / 2
google
Details
- Product number
- 6859701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- cabazitaxelum 60 mg ut cabazitaxeli isopropanoli solvatum, acidum citricum, ethanolum anhydricum 1092 mg, polysorbatum 80, macrogolum 400, ad solutionem pro 6 ml.
Articles (1)
Cabazitaxel-Teva 60 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
60.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1092.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
Reimbursement information
Public price
CHF 2690.90
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/02/2023
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68597
- Drug name
- Cabazitaxel-Teva, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01CD04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 11/10/2022
- Authorization expiration date
- 10/10/2027
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CABAZITAXEL Teva conc perf 60 mg/6ml flac 6 ml
- Description (DE)
- CABAZITAXEL Teva Inf Konz 60 mg/6ml Durchstf 6 ml
- Market launch
- 11/10/2022
- Narcotic (BTM)
- No